Maximum Dose: Tirzepatide offers the highest weekly dose at 15 mg, while dulaglutide caps at 4.5 mg
Comparative effectiveness of allopurinol, febuxostat and benzbromarone on renal function in chronic kidney disease patients with hyperuricemia: a 13-year inception cohort study
For instance, in the CALERIE trial, which involved healthy middle-aged adults undergoing a modest caloric restriction of approximately 12% over two years, areal BMD was observed to decline by 1% to 2% annually at the spine and hip
Potential for Relapse As with any addiction disorder, the potential for relapse with GHB dependence is high, with a 70% chance after moving through the withdrawal stage
***Based on a 6-month clinical trial (n=180) of individuals who were enrolled between FebruaryApril 2024, with overweight or obesity taking semaglutide or tirzepatide for weight loss and related outcomes through the WW Clinic Program and participating in the GLP-1 companion nutrition program